This Common Strategy highlights the achievements of STARS and focusses on the opportunities to strengthen regulatory science and knowledge. Based on the various STARS activities, the status was described and recommendations were developed together with key stakeholders. Bringing these key players of drug development together, resulted in this strategic document, the "STARS Common Strategy".

This document is the STARS road map for the implementation of support activities and training programmes, with the goal to strengthen regulatory sciences and improve successful outcomes from innovative and academic-driven clinical research projects.